Rare diseases
Investigational molecules
Locations
Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
FinlandStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
FinlandStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
FinlandStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
FinlandStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
FinlandStudy on the Effects of Tasipimidine for Patients with Insomnia Disorder
FinlandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FinlandStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
FinlandLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
FinlandSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
FinlandEfficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
FinlandEfficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
